Therefore, we aimed to investigate the glycosylation status of FH during the acute phase and remission in four SP-HUS patients and evaluated the complement regulatory function of FH purified from SP-HUS patient serum during the acute phase and remission. This evidence concerns the gene FH and hemolytic-uremic syndrome.